Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
J Endocrinol 2014;221:2937
[17] The magnitude of improvement correlated with the amount of weight lost
[12] IMPORTANT SAFETY INFORMATION : Contact your healthcare provider immediately if you experience: Severe, persistent abdominal pain, with or without vomiting (possible pancreatitis) Pain in the upper right abdomen, fever, or yellowing of skin/eyes (possible gallbladder problems) Minimal urination, dizziness, or extreme thirst (possible kidney problems) Severe abdominal distention or inability to pass gas or stool (possible intestinal obstruction) Persistent vomiting or diarrhea can lead to dehydration and electrolyte imbalances requiring medical attention
doi: 10.1002/dmrr.3070 Summary Keywords GLP-1 receptor agonists, thyroid disorders, thyroid cancer, meta-analysis, randomized controlled trials Citation Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X and Liu J (2022) Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
